Healthcare IT Today
JUNE 2, 2023
Rather than try to innovate from within healthcare, there are opportunities to disrupt the model by bringing proven solutions and innovations from other industries into healthcare. Larger companies tend to be less self-disruptive and, therefore, less innovative. But here too is where the opportunity lies.
Clear Arch Health
FEBRUARY 1, 2023
As the global healthcare industry continues to confront challenges posed by the COVID-19 pandemic, Clear Arch Health proves its value as the go-to resource for healthcare providers in need of consultancy services, logistical and technical support, and viable solutions for scaling up programs easier.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Blawg
DECEMBER 26, 2017
Issuing these guideline documents is a further step towards creating some predictability for folks in the industry who may shy away from including certain functionality in products for fear of being subject to unknown sorts of regulatory review by the FDA. by David Harlow […] article was originally published on HealthBlawg and.
Lloyd Price
AUGUST 23, 2018
Interoperability is an overlapping set of technical and policy challenges, from data access to common data models to information exchange to workflow integration – and these challenges often pose a barrier to healthcare innovation. Today, as health IT community leaders get together at the CMS Blue Button 2.0
Health Blawg
DECEMBER 26, 2017
Issuing these guideline documents is a further step towards creating some predictability for folks in the industry who may shy away from including certain functionality in products for fear of being subject to unknown sorts of regulatory review by the FDA. by David Harlow […] article was originally published on HealthBlawg and.
Health Blawg
DECEMBER 26, 2017
Issuing these guideline documents is a further step towards creating some predictability for folks in the industry who may shy away from including certain functionality in products for fear of being subject to unknown sorts of regulatory review by the FDA. by David Harlow […] article was originally published on HealthBlawg and.
Health Blawg
DECEMBER 26, 2017
Issuing these guideline documents is a further step towards creating some predictability for folks in the industry who may shy away from including certain functionality in products for fear of being subject to unknown sorts of regulatory review by the FDA. by David Harlow […] article was originally published on HealthBlawg and.
Expert insights. Personalized for you.
93 
Let's personalize your content